Page 195 - New epidemiological and PSMA-expression based paradigms in salivary gland tumors

12.5 List of publications
Malignant transformation of salivary gland pleomorphic adenoma: Proof of principle. Valstar MH, Mast H, ten Hove I, Moonen LR, Balm AJM, Smeele LE, Koljenović S, Dinjens WNM, van Velthuysen MF.
The Journal of Pathology: Clinical Research 2021; 7(5):432-437
The tubarial glands paper: A starting point. A reply to comments.
Valstar MH, de Bakker BS, Steenbakkers RJHM, de Jong KH, Smit LA, Klein Nulent TJW, van Es RJJ, Hofland I, de Keizer B, Jasperse B, Balm AJM, van der Schaaf A, Langendijk JA, Smeele LE, Vogel WV.
Radiotherapy and Oncology. 2021; 154: 308-311
Risk of breast cancer in women with a previous salivary gland carcinoma
or pleomorphic adenoma in the Netherlands.
Valstar MH, Schaapveld M, van den Broek EC, van Velthuysen MF, de Ridder M, Schmidt MK, van Dijk BAC, Balm AJM, Smeele LE.
Cancer Medicine. 2021; 10(1):424-434
The tubarial salivary glands: A potential new organ at risk for radiotherapy. Valstar MH, de Bakker BS, Steenbakkers RJHM, de Jong KH, Smit LA, Klein Nulent TJW, van Es RJJ, Hofland I, de Keizer B, Jasperse B, Balm AJM, van der Schaaf A,
Langendijk JA, Smeele LE, Vogel WV.
Radiotherapy and Oncology. 2021; 154: 292-298
Validated prognostic nomograms for patients with parotid carcinoma predicting 2-and 5-year tumor recurrence-free interval probability. Peeperkorn S, Meulemans J, Lierde CV, Laenen A, Valstar MH, Balm AJ, Delaere P, vander Poorten V Frontiers in Oncology. 2020; 10: 1535
Natural history of Recurrent Pleomorphic Adenoma: Implications on management. Valstar MH, Andreasen S, Bhairosing P, McGurk M.
Head Neck. 2020; 42(8):2058-2066
12
List of publications
193